argenx SE (ARGX)
396.88
-1.94
(-0.49%)
USD |
NASDAQ |
May 08, 10:32
argenx Shareholders Equity (Quarterly): 4.098B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.098B |
June 30, 2023 | 2.858B |
December 31, 2022 | 2.814B |
June 30, 2022 | 2.970B |
December 31, 2021 | 2.534B |
June 30, 2021 | 2.952B |
December 31, 2020 | 1.674B |
June 30, 2020 | 1.818B |
December 31, 2019 | 1.180B |
June 30, 2019 | 756.55M |
June 30, 2019 | 756.55M |
December 31, 2018 | 615.87M |
Date | Value |
---|---|
June 30, 2018 | 384.97M |
June 30, 2018 | 384.97M |
December 31, 2017 | 413.81M |
June 30, 2017 | 171.88M |
December 31, 2016 | 66.65M |
June 30, 2016 | 83.87M |
December 31, 2015 | 40.76M |
June 30, 2015 | 49.56M |
December 31, 2014 | 60.90M |
June 30, 2014 | 23.88M |
March 31, 2014 | 27.33M |
December 31, 2013 | 29.97M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
756.55M
Minimum
Jun 2019
4.098B
Maximum
Dec 2023
2.219B
Average
2.534B
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
TC BioPharm (Holdings) PLC | 3.421M |
Trinity Biotech PLC | -23.95M |
Ascendis Pharma A/S | -257.21M |
Adaptimmune Therapeutics PLC | 39.51M |
Biodexa Pharmaceuticals Plc | 5.959M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.542B |
Total Liabilities (Quarterly) | 444.95M |
Current Ratio | 9.749 |